Alterity Therapeutics Ltd Files For Mixed Shelf Of Up To $50M
Alterity Therapeutics Ltd Files For Mixed Shelf Of Up To $50M
Immuron Ltd Owned Ateria Health Launches Juvia in Australia
Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the tr
Comparing Baudax Bio (NASDAQ:BXRX) & Curative Biotechnology (OTCMKTS:CUBT)
Curative Biotechnology (OTCMKTS:CUBT – Get Rating) and Baudax Bio (NASDAQ:BXRX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two business
Shenzhen Bioeasy Biotechnology Unit Gets Registration Certificates for Medical Devices
01:45 AM EDT, 10/24/2022 (MT Newswires) -- Shenzhen Xiupu Biotechnology, a unit of Shenzhen Bioeasy Biotechnology (SHE:300942), received registration certificates from the Guangdong Provincial Drug Ad
Assenagon Asset Management S.A. Acquires 162,531 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI)
Assenagon Asset Management S.A. boosted its holdings in shares of Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Rating) by 651.2% in the 2nd quarter, according to its most recent Form 13F filing with
Commonwealth Equity Services LLC Sells 173 Shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)
Commonwealth Equity Services LLC trimmed its position in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE – Get Rating) by 1.8% during the 2nd quarter, according to its most re